Abstract:OBJECTIVE:To evaluate the efficacy and safety of submucosal tunneling endoscopic resection (STER) and endoscopic submucosal excavation (ESE) for upper gastroenterology submucosal tumors (SMT) originating from the muscularis propria (MP) layer.METHODS:Clinicopathological and endoscopic data of 42 cases with upper gastroenterology tumors originating from the MP layer who were treated with STER (n=28) or ESE (n=14) between April 2013 and December 2016 in Peking University Third Hospital were retrospectively analyzed. The treatment and complications of the two groups were compared.RESULTS:In the study, 42 cases were all resected by therapeutic endoscopy successfully．There was no significant difference (STER vs. ESE) in gender, age, mean tumor size [1.5 (1.0-6.0) cm vs. 1.3 (0.5-2.0) cm, P=0.056]. STER was superior to ESE with reduced sutured time [3.5 (1.0-11.0) min vs. 8.0 (2.0-33.0) min, P=0.006], but more resection time [46.5 (11.0-163.0) min vs.19.5 (6.0-56.0) min, P=0.007]. There was statistical difference between the two groups in resection time or sutured time, but no significant difference (STER vs. ESE) in total operative time [52.0 (14.0-167.0) min vs. 31.5 (10.0-88.0) min, P=0.080]. En bloc resection rates (92.9% vs. 85.7%), hospital stay duration and complications (10.7 vs. 0.0) were similar in the STER and ESE groups. One case developed mediastinal emphysema and 2 pneumonia after operation in STER group, and all of them recovered uneventfully after conservative treatments; There were no complications in the ESE group. After operation, 28 cases of leiomyoma and 14 cases of stromal tumor were diagnosed by routine pathological and immunohistochemical staining. Among them, 6 cases of stromal tumors in group STER were all extremely low risk, 4 cases of stromal tumors in group ESE were extremely low risk, 4 cases of stromal tumors in group ESE were medium risk (the size of the lesion was about 1.0-2.0 cm, and mitotic figures counted (6-8)/50 high power field). The median follow-up time of all the patients was 46.5 (24-60) months, and the shortest follow-up time for medium risk stromal tumors was 32 months. No residual tumor, recurrence and implantation in the tunnel were observed.CONCLUSION:STER or ESE can be used as an effective and safe option for treatment of submucosal tumors originating from the muscularis propria of the upper digestive tract. Compared with STER, ESE had shorter resection time but longer wound closure time. There was no significant difference in total operation time.

Tu1207 ENDOSCOPIC SUBMUCOSAL TUNNEL RESECTION FOR ESOPHAGEAL SUBEPITHELIAL LESION: A SINGLE-CENTER STUDY

Tu1179 ENDOSCOPIC SUBMUCOSAL TUNNEL RESECTION(STER) FOR ESOPHAGEAL SUBEPITHELIAL LESIONS(SELS) IN THE ESOPHAGOGASTRIC JUNCTION: A SINGLE-CENTER STUDY

Clinical analysis of endoscopic resection for submucosal tumors in the esophagogastric junction

Submucosal Tunnel Endoscopic Resection for Esophageal Submucosal Tumors: A Multicenter Study.

Endoscopic Submucosal Dissection for the Treatment of Large Gastric Submucosal Tumors Originating from the Muscularis Propria Layer: a Single Center Study.

[Submucosal Tunneling Endoscopic Resection in the Treatment of Esophageal Submucosal Tumors Originating from Muscularis Propria Layer].

Preliminary Exploration on Submucosal Tunneling Endoscopic Resection for Middle and Lower Esophagus Submucosal Tumors

Endoscopic Resection of Large Subepithelial Esophageal Lesions Via Submucosal Tunneling Endoscopic Resection and Endoscopic Submucosal Dissection: a Single-Center, Retrospective Cohort Study.

Open Submucosal Tunneling Endoscopic Resection for Special Submucosal Tumors Originating from the Muscularis Propria

Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases.

The Retrospective Comparison Between Submucosal Tunneling Endoscopic Resection and Endoscopic Submucosal Excavation for Managing Esophageal Submucosal Tumors Originating from the Muscularis Propria Layer

Mo1126 COMPARISON BETWEEN ENDOSCOPIC SUBMUCOSAL DISSECTION AND SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION FOR ESOPHAGEAL SUBMUCOSAL TUMORS ORIGINATING FROM THE MUSCULARIS PROPRIA LAYER

Endoscopic Submucosal Dissection for the Treatment of Gastrointestinal Submucosal Tumors Originated from the Muscularis Propria Layer

[Comparative Treatment Analysis of Upper Gastroenterology Submucosal Tumors Originating from Muscularis Propria Layer: Submucosal Tunneling Endoscopic Resection Versus Endoscopic Submucosal Excavation].

A Sub-epithelial Lesion Algorithm For Endoscopic (SAFE) Resection In The Upper Gastrointestinal Tract

Application of Endoscopic Submucosal Dissection in Upper Gastrointestinal Associated Lesions

Efficacy and safety of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors with more than 1-year' follow-up: a systematic review and meta-analysis.

Long-term Outcomes of Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Submucosal Tumors

Submucosal tunneling endoscopic resection for submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a feasibility study (with videos)

Submucosal Tunnel Endoscopic Resection for Extraluminal Tumors: a Novel Endoscopic Method for En Bloc Resection of Predominant Extraluminal Growing Subepithelial Tumors or Extra-Gastrointestinal Tumors (with Videos)

Ligation-assisted endoscopic submucosal resection following unroofing technique for small esophageal subepithelial lesions originating from the muscularis propria